X0306 4 2013-02-01 0 0000885590 Valeant Pharmaceuticals International, Inc. VRX 0001387813 Kornwasser Laizer 4787 LEVY STREET MONTREAL A8 H4R 2P9 QUEBEC, CANADA 0 1 0 0 EVP, Company Group Chairman Restricted Share Units 0 2013-02-01 4 A 0 45000 0 A Common Shares, no par value 45000 45000 D Each Restricted Share Unit ("RSUs") represents a contingent right to receive between zero and three common shares, no par value, of Valeant Pharmaceuticals International, Inc. ("Valeant"), subject to performance based vesting criteria. See note (2). The performance based RSUs are eligible to vest on the achievement of TSR targets ranging from 10% to 30% over a base price of $64.17 on each of three measurement dates: 25% would vest on November 1, 2015, 50% on February 1, 2016 and 25% on May 1, 2016, with early vesting possible at higher TSR levels. by: Nicholas Zanoni for Laizer Kornwasser 2013-02-04